1-1 of 1
R. Aguillon, MD
Close
Sort by
Journal Articles

A Phase I Study of Immune Gene Therapy for Patients with CLL Using a Membrane-Stable, Humanized CD154.

William G. Wierda, MD, PhD, J. Castro, MD, R. Aguillon, MD, A. Jalayer, RN, J. McMannis, PhD, C. Prussak, PhD, M. Keating, MB, BS, T. Kipps, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2040.
https://doi.org/10.1182/blood.V110.11.2040.2040
Published: 2007